The SGLT2 inhibitor increased sodium and reduced neurocognitive dysfunction in patients with chronic hyponatremia due to the syndrome of inappropriate antidiuresis.
Medscape Medical News

Leave a Reply

Your email address will not be published. Required fields are marked *